Method of making a skin care composition
A method of making a skin composition that includes an effective amount of skin care agent selected to inhibit HMGB1 stimulation of human melanocytes. The method includes determining the level of high-mobility group protein B1 (HMGB1), messenger RNA associated with the expression and/or regulation of HMGB1 (HMGB1 mRNA), and/or micro-RNA associated with the expression and/or regulation of HMGB1 (HMGB1 miRNA) present in the test sample, and identifying the test agent as a skin tone agent when there is no increase in HMGB1 level, a downregulation in transcription of HMGB1 mRNA, and/or an upregulation of HMGB1 miRNA. The method also includes identifying a test agent as a skin tone agent when the test agent inhibits or prevents an increase in melanocyte dendricity and/or body size caused by HMGB1, and incorporating the skin tone agent in a dermatologically acceptable carrier.
The Procter & Gamble Company
G G C G A G A G C C G G C G C
G01N G01N C12Q G01N A61Q G01N A61K G01N C12Q C12Q G01N G01N C12Q G01N C12Q
inventional additional inventional inventional inventional additional inventional inventional additional inventional inventional additional inventional inventional additional
Wenzhu Leo Timothy Tomohiro
Zhao Laughlin, II Hakozaki